Family · Pharmaceutical analytical standards
Afacifenacin
An investigational molecule studied in the late 2000s for overactive bladder and nocturia: it completed some phase II studies but has not been approved. This family brings together the active ingredient and other impurities.
Did you know?It has a double mechanism: besides blocking the bladder's muscarinic receptors, it blocks sodium channels and so dampens signals from the bladder's sensory nerves.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
